Report Detail
Global (United States, European Union and China) Diabetes Drug Market Research Report 2019-2025
- RnM3702438 |
- 27 August, 2019 |
- Global |
- 126 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.
The analysis shows human insulins and analogues dominated the antidiabetics market in 2017.
In 2019, the market size of Diabetes Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetes Drug.
This report studies the global market size of Diabetes Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diabetes Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Eli Lilly
Novo Nordisk
Abbott
AstraZeneca
Biocon
Sunpharma
Sanofi
Novartis
Merck
Pfizer
Daiichi Sankyo
Boehringer Ingelheim
Akros Pharma
Amgen
Adocia
Peptron
Takeda
Market Segment by Product Type
Insulin
Sensitizers
SGLT-2 Inhibitors
Alpha-glucosidase Inhibitors
Secretagogues
Peptide Analogs
Others
Market Segment by Application
Hospital
Clinic
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Diabetes Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diabetes Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Diabetes Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Diabetes Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Insulin
- 1.3.3 Sensitizers
- 1.3.4 SGLT-2 Inhibitors
- 1.3.5 Alpha-glucosidase Inhibitors
- 1.3.6 Secretagogues
- 1.3.7 Peptide Analogs
- 1.3.8 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Diabetes Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Diabetes Drug Market Size
- 2.1.1 Global Diabetes Drug Revenue 2014-2025
- 2.1.2 Global Diabetes Drug Sales 2014-2025
- 2.2 Diabetes Drug Growth Rate by Regions
- 2.2.1 Global Diabetes Drug Sales by Regions 2014-2019
- 2.2.2 Global Diabetes Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Diabetes Drug Sales by Manufacturers
- 3.1.1 Diabetes Drug Sales by Manufacturers 2014-2019
- 3.1.2 Diabetes Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Diabetes Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetes Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Diabetes Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Diabetes Drug Price by Manufacturers
- 3.4 Key Manufacturers Diabetes Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Diabetes Drug Market
- 3.6 Key Manufacturers Diabetes Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Insulin Sales and Revenue (2014-2019)
- 4.1.2 Sensitizers Sales and Revenue (2014-2019)
- 4.1.3 SGLT-2 Inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Alpha-glucosidase Inhibitors Sales and Revenue (2014-2019)
- 4.1.5 Secretagogues Sales and Revenue (2014-2019)
- 4.1.6 Peptide Analogs Sales and Revenue (2014-2019)
- 4.1.7 Others Sales and Revenue (2014-2019)
- 4.2 Global Diabetes Drug Sales Market Share by Type
- 4.3 Global Diabetes Drug Revenue Market Share by Type
- 4.4 Diabetes Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Diabetes Drug Sales by Application
6 United States
- 6.1 United States Diabetes Drug Breakdown Data by Company
- 6.2 United States Diabetes Drug Breakdown Data by Type
- 6.3 United States Diabetes Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Diabetes Drug Breakdown Data by Company
- 7.2 European Union Diabetes Drug Breakdown Data by Type
- 7.3 European Union Diabetes Drug Breakdown Data by Application
8 China
- 8.1 China Diabetes Drug Breakdown Data by Company
- 8.2 China Diabetes Drug Breakdown Data by Type
- 8.3 China Diabetes Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Diabetes Drug Breakdown Data by Company
- 9.2 Rest of World Diabetes Drug Breakdown Data by Type
- 9.3 Rest of World Diabetes Drug Breakdown Data by Application
- 9.4 Rest of World Diabetes Drug Breakdown Data by Countries
- 9.4.1 Rest of World Diabetes Drug Sales by Countries
- 9.4.2 Rest of World Diabetes Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Eli Lilly
- 10.1.1 Eli Lilly Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.1.4 Diabetes Drug Product Introduction
- 10.1.5 Eli Lilly Recent Development
- 10.2 Novo Nordisk
- 10.2.1 Novo Nordisk Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.2.4 Diabetes Drug Product Introduction
- 10.2.5 Novo Nordisk Recent Development
- 10.3 Abbott
- 10.3.1 Abbott Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.3.4 Diabetes Drug Product Introduction
- 10.3.5 Abbott Recent Development
- 10.4 AstraZeneca
- 10.4.1 AstraZeneca Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.4.4 Diabetes Drug Product Introduction
- 10.4.5 AstraZeneca Recent Development
- 10.5 Biocon
- 10.5.1 Biocon Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.5.4 Diabetes Drug Product Introduction
- 10.5.5 Biocon Recent Development
- 10.6 Sunpharma
- 10.6.1 Sunpharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.6.4 Diabetes Drug Product Introduction
- 10.6.5 Sunpharma Recent Development
- 10.7 Sanofi
- 10.7.1 Sanofi Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.7.4 Diabetes Drug Product Introduction
- 10.7.5 Sanofi Recent Development
- 10.8 Novartis
- 10.8.1 Novartis Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.8.4 Diabetes Drug Product Introduction
- 10.8.5 Novartis Recent Development
- 10.9 Merck
- 10.9.1 Merck Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.9.4 Diabetes Drug Product Introduction
- 10.9.5 Merck Recent Development
- 10.10 Pfizer
- 10.10.1 Pfizer Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Diabetes Drug
- 10.10.4 Diabetes Drug Product Introduction
- 10.10.5 Pfizer Recent Development
- 10.11 Daiichi Sankyo
- 10.12 Boehringer Ingelheim
- 10.13 Akros Pharma
- 10.14 Amgen
- 10.15 Adocia
- 10.16 Peptron
- 10.17 Takeda
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Diabetes Drug Sales Channels
- 11.2.2 Diabetes Drug Distributors
- 11.3 Diabetes Drug Customers
12 Market Forecast
- 12.1 Global Diabetes Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Diabetes Drug Sales Forecast by Type
- 12.3 Global Diabetes Drug Sales Forecast by Application
- 12.4 Diabetes Drug Forecast by Regions
- 12.4.1 Global Diabetes Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Diabetes Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Diabetes Drug. Industry analysis & Market Report on Diabetes Drug is a syndicated market report, published as Global (United States, European Union and China) Diabetes Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Diabetes Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
